Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

GLOBAL HEALTH LTD.

NSE : MEDANTABSE : 543654ISIN CODE : INE474Q01031Industry : Hospital & Healthcare ServicesHouse : Private

BSE1191.0525.6 (+2.2 %)

PREV CLOSE ( ) 1165.45

OPEN PRICE ( ) 1168.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 60798

TODAY'S LOW / HIGH ( )1164.10 1200.75

52 WK LOW / HIGH ( )936.05 1301

NSE1190.6024.5 (+2.1 %)

PREV CLOSE( ) 1166.10

OPEN PRICE ( ) 1167.60

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1190.60 (69)

VOLUME 412226

TODAY'S LOW / HIGH( ) 1163.70 1200.00

52 WK LOW / HIGH ( )935.5 1298.8

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 13-08 2004

Management Info

Naresh Trehan - Chairman Naresh Trehan - Managing Director

Registered Office

Address Medanta- Mediclinic,E-18, Defence Colony,,
New Delhi,
Delhi-110024

Phone 011-44114411

Email info@medanta.org

Website www.medanta.org

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

19Jun Global Health informs about analyst meet
Global Health has informed that the Company’s Management will meet Inves..

13Jun Global Health informs about analyst meet
Global Health has informed that the Company’s Management will meet Inves..

03Jun Global Health informs about analyst meet
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obliga..

27May Global Health informs about analyst me
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obliga..

15May Global Health informs about allotment
Pursuant to Regulation 30 of SEBI Listing Regulations, Global Health has..

Financials

Rs. in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	934.120000000001	4615.28
Gross Profit	1258.87	6230.47
Operating Profit	2208.62	8559.45
Net Sales	8028.68	32041.46

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Apollo Hospital Ent. (BSE) 7563.95 (1.55%)	M.Cap ( in Cr)108758.00
Kovai Medical Center (BSE) 5949.40 (1.52%)	M.Cap ( in Cr)6509.99
RainbowChildrenS Med (BSE) 1587.00 (4.60%)	M.Cap ( in Cr)16116.25
Aster DM Healthcare (BSE) 648.50 (9.47%)	M.Cap ( in Cr)33600.15
Thyrocare Tech. (BSE) 1021.75 (3.85%)	M.Cap ( in Cr)5414.71

Shareholding Pattern

	NON-INSTITUTION	43.28%
	PROMOTERS	33.03%
	MUTUAL FUNDS/UTI	10.36%
	FI/BANKS/INSURANCE	0.69%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Invesco India Focus...	4.64
HSBC Consumption Fu...	3.20
PGIM India Healthca...	3.04
Invesco India Midca...	2.87
Invesco India Large...	2.53
Invesco India Small...	2.49
PGIM India Aggressi...	2.27

Risk Disclosures on Derivatives

Smart Quotes

GLOBAL HEALTH LTD.